ATE534905T1 - Cop1-moleküle und verwendungen davon - Google Patents

Cop1-moleküle und verwendungen davon

Info

Publication number
ATE534905T1
ATE534905T1 AT04795352T AT04795352T ATE534905T1 AT E534905 T1 ATE534905 T1 AT E534905T1 AT 04795352 T AT04795352 T AT 04795352T AT 04795352 T AT04795352 T AT 04795352T AT E534905 T1 ATE534905 T1 AT E534905T1
Authority
AT
Austria
Prior art keywords
cop1
cop1 molecules
molecules
detecting
provides
Prior art date
Application number
AT04795352T
Other languages
English (en)
Inventor
David Dornan
Dorothy French
Vishva Dixit
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE534905T1 publication Critical patent/ATE534905T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/9015Ligases (6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Liquid Crystal Substances (AREA)
  • Artificial Filaments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AT04795352T 2004-10-14 2004-10-14 Cop1-moleküle und verwendungen davon ATE534905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/034174 WO2006043938A1 (en) 2004-10-14 2004-10-14 Cop1 molecules and uses thereof

Publications (1)

Publication Number Publication Date
ATE534905T1 true ATE534905T1 (de) 2011-12-15

Family

ID=34959031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04795352T ATE534905T1 (de) 2004-10-14 2004-10-14 Cop1-moleküle und verwendungen davon

Country Status (11)

Country Link
US (2) US7785815B2 (de)
EP (2) EP1802978B1 (de)
JP (1) JP4678882B2 (de)
CN (1) CN101080638A (de)
AT (1) ATE534905T1 (de)
AU (2) AU2004324176B2 (de)
CA (1) CA2584197A1 (de)
IL (2) IL182500A0 (de)
MX (1) MX2007004342A (de)
NZ (1) NZ554438A (de)
WO (1) WO2006043938A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802978B1 (de) 2004-10-14 2011-11-23 Genentech, Inc. Cop1-moleküle und verwendungen davon
US10261321B2 (en) 2005-11-08 2019-04-16 Lumus Ltd. Polarizing optical system
EP1981984A2 (de) * 2005-12-31 2008-10-22 Genentech, Inc. Phosphorylierte cop1-moleküle und verwendungen davon
KR101711860B1 (ko) * 2008-01-25 2017-03-03 베르그 엘엘씨 발암성, 종양 진행 및 치료 효능을 평가하는 분석 시스템
WO2009117448A1 (en) * 2008-03-18 2009-09-24 Mendel Biotechnology, Inc. Enhancement of plant yield, vigor and stress tolerance
US9222086B2 (en) 2009-09-23 2015-12-29 Protiva Biotherapeutics, Inc. Compositions and methods for silencing genes expressed in cancer
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (de) 2014-09-26 2021-03-24 Terumo BCT, Inc. Geplante fütterung
IL235642B (en) 2014-11-11 2021-08-31 Lumus Ltd A compact head-up display system is protected by an element with a super-thin structure
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
JP7187022B2 (ja) 2016-10-09 2022-12-12 ルムス エルティーディー. 長方形導波路を使用する開口乗算器
CN113031165B (zh) 2016-11-08 2023-06-02 鲁姆斯有限公司 导光装置、其光学组件及其对应的生产方法
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
JP7174929B2 (ja) 2017-07-19 2022-11-18 ルムス エルティーディー. Loeを介するlcos照明
WO2020174433A1 (en) 2019-02-28 2020-09-03 Lumus Ltd. Compact collimated image projector
KR20210151782A (ko) 2019-04-15 2021-12-14 루머스 리미티드 광-유도 광학 소자 제조 방법
CA3155597C (en) 2019-12-08 2023-02-14 Lumus Ltd. Optical systems with compact image projector
DE202021104723U1 (de) 2020-09-11 2021-10-18 Lumus Ltd. An ein optisches Lichtleiterelement gekoppelter Bildprojektor
EP4314244B1 (de) 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN119587474A (zh) * 2024-12-20 2025-03-11 中国人民解放军新疆军区总医院 一种肝靶向化疗药物纳米胶束制备方法、化疗药物及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5527676A (en) 1989-03-29 1996-06-18 The Johns Hopkins University Detection of loss of the wild-type P53 gene and kits therefor
DE69233079T2 (de) * 1991-02-01 2004-04-01 OSI Pharmaceuticals, Inc., Uniondale Immunoassay zum nachweis des mutanten p53 polypeptids in biologischen flüssigkeiten
US6020135A (en) * 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US8053477B2 (en) * 2002-03-29 2011-11-08 University Of Maryland, Baltimore Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same
DE60200248T2 (de) * 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
EP1802978B1 (de) 2004-10-14 2011-11-23 Genentech, Inc. Cop1-moleküle und verwendungen davon

Also Published As

Publication number Publication date
AU2004324176A1 (en) 2006-04-27
EP1802978B1 (de) 2011-11-23
US7785815B2 (en) 2010-08-31
IL211255A0 (en) 2011-04-28
JP2008517266A (ja) 2008-05-22
CN101080638A (zh) 2007-11-28
US20110045474A1 (en) 2011-02-24
EP1802978A1 (de) 2007-07-04
IL182500A0 (en) 2007-09-20
EP2302388A1 (de) 2011-03-30
US20080009458A1 (en) 2008-01-10
AU2010219438A1 (en) 2010-10-14
WO2006043938A1 (en) 2006-04-27
CA2584197A1 (en) 2006-04-27
JP4678882B2 (ja) 2011-04-27
NZ554438A (en) 2009-11-27
MX2007004342A (es) 2007-07-16
AU2004324176B2 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
ATE534905T1 (de) Cop1-moleküle und verwendungen davon
IL180997A0 (en) Diagnostic methods and kits utilizing platelet biomarkers for cancer
AU2006316189A8 (en) Novel quantitative and qualitative analysis apparatus for measuring the body fluid
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
GB0612649D0 (en) No title
DE602006002251D1 (de) Messvorrichtungsanzeigevorrichtung, anzeigeverfahren dafür und damit ausgestattetes hybridfahrzeug
AU305356S (en) Analyte test meter
ATE424560T1 (de) Marker für neuromyelitis optica
DE602005009702D1 (de) Esr1 und gebärmutterhalskrebs
WO2008048970A3 (en) Synthetic antibodies
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
EP1700096A4 (de) Nachweis von proteinen und prionen mit veränderter konformation
ATE513216T1 (de) Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome
WO2008048508A3 (en) Prognostic biomarkers in patients with ovarian cancer
DE602006019404D1 (de) Docetaxel-immuntest
WO2007092173A3 (en) Raman spectroscopic lateral flow test strip assays
DK1864129T3 (da) Doxurubicin-immunassay
WO2007056523A3 (en) Methods for diagnosing and monitoring the progression of cancer
ATE479898T1 (de) Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
EP1776470A4 (de) Reagenzien, kits und verfahren für den immunnachweis von epitopen auf molekülen
IL173843A0 (en) Assay for coronaviruses, reagents for use therein and kits containing the same
BRPI0606685A2 (pt) anticorpos gitr para o diagnóstico de nsclc
IL174195A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
ATE533860T1 (de) Reagenzien und verfahren zur detektion von neisseria gonorrhoeae